Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/10/24 | 8-K | Current report filing |
|
   |
94 |
| 12/10/24 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
23 | |
| 12/09/24 | 8-K | Current report filing |
|
|
4 |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/05/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
